Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

XSP-BENA EXPECTORANT

Approval Number

SIN03335P

Drug Name

XSP-BENA EXPECTORANT

Product Name

XSP-BENA EXPECTORANT

Approval Date

June 16, 1989

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Pharmacy Only

Formulation Information

Dosage Form

SUSPENSION

Route of Administration

ORAL

Medical Information

ATC Code

R05CA10

ATC Item Name

combinations

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

Ingredient Name

AMMONIUM CHLORIDE

Strength

135 mg/5 ml

Drug MonographAmmonium chloride

Ingredient Name

DIPHENHYDRAMINE HCl

Strength

14 mg/5 ml

Drug MonographDiphenhydramine

Ingredient Name

SODIUM CITRATE

Strength

57.5 mg/5 ml

Drug MonographSodium citrate

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy